Covid Jab Side Effects: MHRA Chief Exec RESIGNS after UK MPs Call for Investigation into Failure to Flag
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for approving drugs and devices and monitors side effects caused by treatments. But the all-party parliamentary group (APPG) on pandemic response and recovery, an influential group of MPs, has raised “serious patient safety concerns”. It has claimed that “far from protecting patients” the regulator operates in a way that “puts them at serious risk”.
The Chief Executive
Dame June said: “It has been an enormous privilege to have led the MHRA through a time of change which is unprecedented in UK medical products regulation. I am especially proud that during the last 5 years the Agency has built a new vigilance system, strengthened international and national partnerships, and delivered regulation which has enabled groundbreaking innovation, from gene therapy for sickle cell disease and the world’s first Covid vaccine, to being close to eradicating polio, and from medical device software to AI diagnostics.”
Clearly the Chief Executive is delusionaal the vigilance system was rendenred not fit for purpose under Raine’s watch, but she remained in the post for the five years ignoring the thousands of Covid jab deaths and harms. thus enabling their continuation. The Chief executive should not be anywhere near a public health role, but yes, she was right in saying that she “made a difference to the lives of everyone in the UK”
MHRA Aware of Heart and Clotting Issues Since March 2021
The Telegraph reported “Some 25 MPs across four parties have written to the health select committee asking for an urgent investigation. In reply, Steve Brine, the health committee chairman, has said an inquiry into patient safety is “very likely”.
In a letter to Mr Brine, the APPG said that there was reason to believe that the MHRA had been aware of post-vaccination heart and clotting issues as early as February 2021, but did not highlight the problems for several months.